<![CDATA[Sequencing CAR T-Cell Therapy With Bispecifics in Follicular Lymphoma]]>

ConferenceCAR T-Cell TherapyBispecific AntibodiesNeutral

AI Analysis

Summary

Dr. Carlos Silva Rondon from Moffitt Cancer Center discussed clinical factors guiding treatment selection between CAR T-cell therapy and bispecific antibodies for follicular lymphoma patients.

Importance:3/10

Sentiment:

0.00

CAR T-Cell TherapyBispecific AntibodiesFollicular LymphomaTreatment SelectionOncology

Read the original article

Published by Cancer Network on July 22, 2026 9:00 PM

Read Original